Efferocytosis is the process by which various phagocytes clear apoptotic cells. In recent years, an increasing body of evidence has emphasized the importance of efferocytosis in maintaining internal homeostasis. Intestinal macrophages play a crucial role in modulating intestinal inflammation and promoting tissue repair. Inflammatory bowel disease (IBD) is a chronic, progressive, and relapsing condition, primarily marked by the presence of ulcers in the digestive tract. The exact mechanisms underlying IBD are not yet fully understood, and current treatment approaches mainly aim at repairing the damaged intestinal mucosa and reducing inflammatory responses to ease symptoms.This article provides new perspectives on IBD treatment and clinical management by examining the expression of macrophage efferocytosis-related molecules, the effects of efferocytosis on IBD development, the various roles of macrophage efferocytosis in IBD, and treatment strategies for IBD that focus on efferocytosis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11876057 | PMC |
| http://dx.doi.org/10.3389/fimmu.2025.1524058 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[The characteristics of pediatric-onset inflammatory bowel disease based on our 20-year-long study].
Orv Hetil
March 2025
1 Semmelweis Egyetem, Általános Orvostudományi Kar, Gyermekgyógyászati Klinika, MTA Kiváló Kutatóhely Budapest, Postafiók 2., 1428 Magyarország.
CKMT1 deficiency contributes to mitochondrial dysfunction and promotes intestinal epithelial cell apoptosis via reverse electron transfer-derived ROS in colitis.
Cell Death Dis
March 2025
National Clinical Research Center for Digestive Diseases, Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China.
Mitochondrial dysfunction contributes to the pathogenesis of ulcerative colitis (UC). As a mitochondrial isozyme of creatine kinases, which control energy metabolism, CKMT1 is thought to be a critical molecule in biological processes. However, the specific role of CKMT1 in intestinal inflammation remains largely unknown.
View Article and Find Full Text PDFBiosilicification-mimicking chiral nanostructures for targeted treatment of inflammatory bowel disease.
Nat Commun
March 2025
School of Pharmacy, China Medical University, Shenyang, China.
The cascade reaction of lipopolysaccharides (LPS), cell-free DNA (cfDNA), and reactive oxygen species (ROS), drives the development of inflammatory bowel disease (IBD). Herein, we construct polyethylenimide (PEI)-L/D-tartaric acid (L/D-TA) complexes templated mesoporous organosilica nanoparticles (MON) (PEI-L/D-TA@MON) by mimicking biosilicification under ambient conditions within seconds. The chiral nanomedicines include four functional moieties, wherein PEI electrostatically attracts cfDNA, tetrathulfide bonds reductively react with ROS, silanol groups adsorb LPS, and L/D-TA enables chiral recognition and inflammatory localization.
View Article and Find Full Text PDFRisk of age-related and disease-related complications and mortality in elderly-onset IBD - a population-based study.
Clin Gastroenterol Hepatol
March 2025
Department of Gastroenterology, Rambam Health Care Campus, Haifa, Israel; B. Rappaport Faculty of Medicine, the Technion - Israel Institute of Technology, Haifa, Israel.
Background & Aims: In this nationwide cohort from Israel (Epi-IIRN), we aimed to characterize risks for age-related complications, mortality and IBD-related surgeries in patients with elderly-onset inflammatory bowel diseases (EO-IBD).
Methods: Data of patients with EO-IBD (≥65 years) diagnosed during 2005-2020 were retrieved from the epi-IIRN database. EO-IBD Patients were compared to 3 age-, sex- and district-matched non-IBD individuals, for age-related outcomes.
The case of a bloody mess - Bictegravir/emtricitabine/tenofovir alafenamide induced colitis.
Clin Biochem
March 2025
Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, ON, Canada; Division of Clinical Biochemistry, Laboratory Medicine Program, University Health Network, Toronto, ON, Canada. Electronic address:
Background: Fecal calprotectin is a marker used to differentiate inflammatory bowel disease versus irritable bowel syndrome and is relevant in the diagnosis of ulcerative colitis and Crohn's disease. Markedly elevated calprotectin from stool samples provides evidence of colonic inflammation to support the diagnosis of pancolitis. This report is the first to demonstrate the clinical significance of fecal calprotectin in supporting the diagnosis of pancolitis induced by the anti-viral drug, Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!